TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2022
Voltar para busca
Dado oficial do USPTO
CLINX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
03/06/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 36, 42
Data de depósito
30/10/2018
Data de registro
17/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/08/2021
Última transação
03/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/11/2017
Primeiro uso no comércio
01/11/2017
Código do desenho
5
Tipo de titular
16
Localização do titular
Quincy, MA, US
Examinador
SOBRAL, CHRISTINA
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the letters "Clin" in bold black letters next to a stylized oversized blue "X".
Titulares e representantes
Titulares
Clin-X, LLC
Representantes
John E. Ottaviani Partridge Snow & Hahn LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trialsproviding business information management services; Providing operational business development assistance to clinical research sites of others; conducting business feasibility studies; providing regulatory submission management assistance with clinical research in the nature of assisting research clinics in the study start-up process for clinical research biopharmaceutical and biotechnology companies; providing business development to a network of investigation sites and providing independent review of clinical trials for business purposes through a network of investigational sites; Patient recruitmentretentionmarketing servicesoperation of telephone call centerdesign of advertising and marketing materials for othersdeveloping and support of plans for patient outreach in the nature of posting of clinical trial notices for the purpose of recruiting patients for participating in clinical trials for the testing of drugsmanagement of traditional and online advertising campaigns to recruit patientsbusiness management services for clinical studies conducted by others
Classe 36
Financial consulting services for clinical studies conducted by others
Classe 42
Consulting services for others in the field of clinical trial planning
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
17/08/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/07/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/07/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/07/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/07/2021
IUAF
USE AMENDMENT FILED
30/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
30/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/03/2021
EX2G
SOU EXTENSION 2 GRANTED
09/03/2021
EXT2
SOU EXTENSION 2 FILED
09/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/03/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2020
EX1G
SOU EXTENSION 1 GRANTED
10/09/2020
EXT1
SOU EXTENSION 1 FILED
10/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/09/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2020
PUBO
PUBLISHED FOR OPPOSITION
14/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/12/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/08/2019
GNFR
FINAL REFUSAL E-MAILED
23/08/2019
CNFR
FINAL REFUSAL WRITTEN
23/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/08/2019
ALIE
ASSIGNED TO LIE
15/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2019
GNRT
NON-FINAL ACTION E-MAILED
06/02/2019
CNRT
NON-FINAL ACTION WRITTEN
06/02/2019
DOCK
ASSIGNED TO EXAMINER
06/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/11/2018
NWAP
NEW APPLICATION ENTERED
02/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CLINX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.